Pharmaceuticals & Animal Health API

NGL Fine-Chem reported Q4FY26 revenue of ₹149.23 Cr, up 17% YoY, driven by broad-based volume growth across products and geographies. EBITDA margin was 14.35% in Q4, impacted by forex MTM provisions a